- Report
- May 2024
- 326 Pages
Global
From €5228EUR$5,450USD£4,491GBP
- Report
- April 2024
- 137 Pages
Global
From €3740EUR$3,899USD£3,213GBP
- Report
- April 2024
- 146 Pages
Global
From €3740EUR$3,899USD£3,213GBP
- Report
- November 2023
- 143 Pages
Global
From €2397EUR$2,499USD£2,059GBP
- Report
- February 2024
- 182 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- October 2023
- 170 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1439EUR$1,500USD£1,236GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,236GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,236GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1199EUR$1,250USD£1,030GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1199EUR$1,250USD£1,030GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1199EUR$1,250USD£1,030GBP
- Report
- November 2023
- 182 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- March 2024
- 200 Pages
Global
From €3981EUR$4,150USD£3,420GBP
- Report
- January 2019
- 144 Pages
Global
From €1319EUR$1,375USD£1,133GBP
€2638EUR$2,750USD£2,266GBP
- Report
- May 2024
- 191 Pages
From €3237EUR$3,374USD£2,781GBP
€3596EUR$3,749USD£3,090GBP
- Report
- April 2023
- 275 Pages
Global
From €3828EUR$3,990USD£3,288GBP
- Report
- February 2023
- 220 Pages
Global
From €7195EUR$7,500USD£6,181GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3358EUR$3,500USD£2,884GBP
Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon.
CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs.
The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more